OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype
Baohua Hou, Yahui Zhang, Peiyu Liang, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 5
Open Access | Times Cited: 146
Baohua Hou, Yahui Zhang, Peiyu Liang, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 5
Open Access | Times Cited: 146
Showing 1-25 of 146 citing articles:
An update on the regulatory mechanisms of NLRP3 inflammasome activation
Seungwha Paik, Jin Kyung Kim, Prashanta Silwal, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 5, pp. 1141-1160
Open Access | Times Cited: 503
Seungwha Paik, Jin Kyung Kim, Prashanta Silwal, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 5, pp. 1141-1160
Open Access | Times Cited: 503
NLRP3 and pyroptosis blockers for treating inflammatory diseases
Rebecca C. Coll, Kate Schroder, Pablo Pelegrı́n
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 8, pp. 653-668
Open Access | Times Cited: 407
Rebecca C. Coll, Kate Schroder, Pablo Pelegrı́n
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 8, pp. 653-668
Open Access | Times Cited: 407
A1/A2 astrocytes in central nervous system injuries and diseases: Angels or devils?
Yan‐Ying Fan, Jing Huo
Neurochemistry International (2021) Vol. 148, pp. 105080-105080
Closed Access | Times Cited: 174
Yan‐Ying Fan, Jing Huo
Neurochemistry International (2021) Vol. 148, pp. 105080-105080
Closed Access | Times Cited: 174
Roles of neuropathology-associated reactive astrocytes: a systematic review
Jill M. Lawrence, Kayla A. Schardien, Brian Wigdahl, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 170
Jill M. Lawrence, Kayla A. Schardien, Brian Wigdahl, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 170
Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950
Sarah E. Corcoran, Reena Halai, Matthew A. Cooper
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 968-1000
Open Access | Times Cited: 116
Sarah E. Corcoran, Reena Halai, Matthew A. Cooper
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 968-1000
Open Access | Times Cited: 116
Microglial NLRP3 inflammasome activates neurotoxic astrocytes in depression-like mice
Shanshan Li, Yinquan Fang, Yihe Zhang, et al.
Cell Reports (2022) Vol. 41, Iss. 4, pp. 111532-111532
Open Access | Times Cited: 107
Shanshan Li, Yinquan Fang, Yihe Zhang, et al.
Cell Reports (2022) Vol. 41, Iss. 4, pp. 111532-111532
Open Access | Times Cited: 107
Neurotoxic A1 astrocytes promote neuronal ferroptosis via CXCL10/CXCR3 axis in epilepsy
Peiyu Liang, Xinyi Zhang, Yahui Zhang, et al.
Free Radical Biology and Medicine (2023) Vol. 195, pp. 329-342
Closed Access | Times Cited: 45
Peiyu Liang, Xinyi Zhang, Yahui Zhang, et al.
Free Radical Biology and Medicine (2023) Vol. 195, pp. 329-342
Closed Access | Times Cited: 45
Inflammasomes in neurological disorders — mechanisms and therapeutic potential
Kishore Aravind Ravichandran, Michael T. Heneka
Nature Reviews Neurology (2024) Vol. 20, Iss. 2, pp. 67-83
Closed Access | Times Cited: 34
Kishore Aravind Ravichandran, Michael T. Heneka
Nature Reviews Neurology (2024) Vol. 20, Iss. 2, pp. 67-83
Closed Access | Times Cited: 34
Pyroptosis in health and disease: mechanisms, regulation and clinical perspective
Yifan Liu, Renjie Pan, Yuzhen Ouyang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Yifan Liu, Renjie Pan, Yuzhen Ouyang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Role of pyroptosis in the pathogenesis of various neurological diseases
Abiola Oladapo, Thomas L. Jackson, Jueliet Menolascino, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 428-446
Closed Access | Times Cited: 26
Abiola Oladapo, Thomas L. Jackson, Jueliet Menolascino, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 428-446
Closed Access | Times Cited: 26
Relationship between inflammation and oxidative stress and its effect on multiple sclerosis
Elsy Janeth Ramos-González, Oscar Kurt Bitzer-Quintero, Genaro Gabriel Ortíz, et al.
Neurología (English Edition) (2024) Vol. 39, Iss. 3, pp. 292-301
Open Access | Times Cited: 24
Elsy Janeth Ramos-González, Oscar Kurt Bitzer-Quintero, Genaro Gabriel Ortíz, et al.
Neurología (English Edition) (2024) Vol. 39, Iss. 3, pp. 292-301
Open Access | Times Cited: 24
NLRP3 regulates alveolar bone loss in ligature‐induced periodontitis by promoting osteoclastic differentiation
Yuyi Chen, Qiudong Yang, C. Lv, et al.
Cell Proliferation (2020) Vol. 54, Iss. 2
Open Access | Times Cited: 116
Yuyi Chen, Qiudong Yang, C. Lv, et al.
Cell Proliferation (2020) Vol. 54, Iss. 2
Open Access | Times Cited: 116
NOD-like receptors in autoimmune diseases
Li Chen, Shiqi Cao, Zemin Lin, et al.
Acta Pharmacologica Sinica (2021) Vol. 42, Iss. 11, pp. 1742-1756
Open Access | Times Cited: 91
Li Chen, Shiqi Cao, Zemin Lin, et al.
Acta Pharmacologica Sinica (2021) Vol. 42, Iss. 11, pp. 1742-1756
Open Access | Times Cited: 91
NLRP3 inflammasome in neurodegenerative disease
Faith L. Anderson, Karl Biggs, Brynn E. Rankin, et al.
Translational research (2022) Vol. 252, pp. 21-33
Open Access | Times Cited: 67
Faith L. Anderson, Karl Biggs, Brynn E. Rankin, et al.
Translational research (2022) Vol. 252, pp. 21-33
Open Access | Times Cited: 67
A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington’s disease
Kai-Po Chen, Kuo‐Feng Hua, Fu-Ting Tsai, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 46
Kai-Po Chen, Kuo‐Feng Hua, Fu-Ting Tsai, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 46
Limin Zhang, Xin Yue, Zhi‐You Wu, et al.
Journal of Neurochemistry (2022) Vol. 162, Iss. 5, pp. 444-462
Closed Access | Times Cited: 45
Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics
Yueran Cui, Haiyang Yu, Zhongqi Bu, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 41
Yueran Cui, Haiyang Yu, Zhongqi Bu, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 41
Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis
Melissa Schepers, Dean Paes, Assia Tiane, et al.
Brain Behavior and Immunity (2022) Vol. 109, pp. 1-22
Open Access | Times Cited: 39
Melissa Schepers, Dean Paes, Assia Tiane, et al.
Brain Behavior and Immunity (2022) Vol. 109, pp. 1-22
Open Access | Times Cited: 39
Central nervous system demyelinating diseases: glial cells at the hub of pathology
Vinicius Gabriel Coutinho Costa, Sheila Espírito-Santo Araújo, Soniza Vieira Alves‐Leon, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Vinicius Gabriel Coutinho Costa, Sheila Espírito-Santo Araújo, Soniza Vieira Alves‐Leon, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials
Maryam Ghasemi, Elham Roshandel, Mozhdeh Mohammadian, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Maryam Ghasemi, Elham Roshandel, Mozhdeh Mohammadian, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
NLRP3 Inflammasome’s Activation in Acute and Chronic Brain Diseases—An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes
Anna Chiarini, Li Gui, C Viviani, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 999-999
Open Access | Times Cited: 23
Anna Chiarini, Li Gui, C Viviani, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 999-999
Open Access | Times Cited: 23
Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease
Gizem Terzioğlu, Tracy L. Young‐Pearse
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 22
Gizem Terzioğlu, Tracy L. Young‐Pearse
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 22
Astrocytes: The Stars in Neurodegeneration?
Katarina Stoklund Dittlau, Kristine Freude
Biomolecules (2024) Vol. 14, Iss. 3, pp. 289-289
Open Access | Times Cited: 13
Katarina Stoklund Dittlau, Kristine Freude
Biomolecules (2024) Vol. 14, Iss. 3, pp. 289-289
Open Access | Times Cited: 13
NLRP3 exacerbates EAE severity through ROS-dependent NET formation in the mouse brain
Da Jeong Byun, Jaeho Lee, Kyungryung Ko, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Da Jeong Byun, Jaeho Lee, Kyungryung Ko, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
The interplay between mitochondrial dysfunction and NLRP3 inflammasome in multiple sclerosis: Therapeutic implications and animal model studies
Alireza Shadab, Mohammad Abbasi‐Kolli, Mansoore Saharkhiz, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116673-116673
Open Access | Times Cited: 9
Alireza Shadab, Mohammad Abbasi‐Kolli, Mansoore Saharkhiz, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116673-116673
Open Access | Times Cited: 9
